Zacks Investment Research
15 Jun 2026, 09:16 UTC · 21w ago
Impact · against what's priced in
Hyster-Yale faces a conflict between improving geopolitical headwinds and deteriorating fundamentals. While the US-Iran agreement reduces supply chain risk, it is offset by an expected quarterly loss of $2.05 per share and a significant revenue decline.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish
The United States and Iran have announced an interim agreement to end hostilities and reopen the Strait of Hormuz.
More positive than 99% of claims this week
Hyster-Yale is expected to report a quarterly loss of $2.05 per share and a 15.9% year-over-year revenue decline.
Continue reading
5 related stories
The rally on the US-Iran agreement is tempered by severe fundamental headwinds, specifically an expected quarterly loss of $2.05 per share and a 15.9% year-over-year revenue decline.
Read from the article alone
No priced-in read yet
As a competitor in the same industry as Hyster-Yale, Texas Instruments may benefit from the broader reduction in systemic risk and material costs following the reopening of the Strait of Hormuz.
Read from the article alone
Scored by the NIS engine · methodology.
Search tags
More negative than 83% of claims this week
Hyster-Yale (HY) shares rose 5.2% following the U.S.-Iran agreement, reflecting optimism over reduced material costs and supply-chain disruptions.
More positive than 64% of claims this week
Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
CNBC
2h ago
−11.5%
Price is moving against the score
$56.45 vs $63.80 close before publication (Jun 12) · not market-adjusted
TEX chart →−27.6%
Price agrees with the score
$26.90 vs $37.18 close before publication (Jun 12) · not market-adjusted
HY chart →
